Product details
| Commercial name | Canigen L | 
| Authorization number | 220052 | 
| Authorization status | Valida | 
| Authorization date | 15-03-2022 | 
| Authorization valid date | nelimitata | 
| Active substance | L. interrogans, serogrup canicola, L. interrogans, serogrup icterohaemorrhagiae | 
| Target species | câini | 
| Therapeutical action | Caini Imunoprofilaxia leptospirozei. | 
| Therapeutic group | Produse biologice | 
| Pharmaceutical form | liofilizat şi solvent pentru suspensie injectabilă | 
| Packaging | flacon x 1 ml | 
| Withdrawal period | Nu este cazul. | 
| Manufacturer | VIRBAC S.A., Franţa | 
| Licence owner | VIRBAC S.A., Franţa | 
| Romanian responsible company | ALTIUS SA | 
| Link to prospectus | click aici pentru a vizualiza prospectul | 
| Link to authorization | |
| Notes | Autorizat prin DCP. | 
| Release Mode | Cu prescripţie | 
| Authorization variations | |||
| 
                                           I. Variatii care necesita evaluare (VRA):  | 
                                   |||
| Variation No. | Date | Variation type | Description | 
| 1 | 17-06-2024 | G.I.18 | Alinierea informatiilor despre produs cu versiunea QRD 9.0, adica actualizarea majora a formatelor QRD, conform Regulamentului (UE) 2019/6, pentru produse medicinale veterinare introduse pe piata in conformitate cu Directiva 2001/82/CE, Directiva 2001/82/CE sau Regulamentul (CE) nr. 726 / 2004. | 
| Authorizations history | ||||
| Commercial name | Authorization number | Authorization date | Authorization valid date | Authorization status | 
| Canigen L | 170204 | 21-09-2017 | 21-09-2022 | Anulata | 
 
 
